2022 Quality Assurance Reporting Requirements (QARR)
- Clarification also available in Portable Document Format (PDF)
November 30, 2022
RE: Clarification #9 for Measurement Year (MY) 2022 Updates
Dear Colleague,
This letter contains information about edits incorporated into the 2022 Quality Assurance Reporting
Requirements (QARR) Technical Specifications for Measurement Year (MY) 2022 reporting. The information contained in this clarification has been incorporated into a revised version of the MY2022 PLD File Specifications. The updated files are posted on our Managed Care Information for Health Plans page. The revised specifications should be used in plans' processing for MY2022 QARR.
This clarification includes the following changes made to the 2022 QARR Technical Specifications Manual and Patient-Level Detail File (PLD).
Change Version | Version Date | Section(s) Changed | Change Summary |
---|---|---|---|
9 | 11.23.2022 | QARR Technical Specifications | To maintain consistency between CMS' 2023 Quality Rating System Measure Technical Specifications and NYS QARR reporting requirements for the Exchange, Blood Pressure Control for Patients With Diabetes (BPD) has been changed to Not Required (NR) for reporting for Qualified Health Plans (QHP) for PPO/EPO and HMO/POS product lines. COVID-19 Immunization Status (Primary and Booster Series) - Added applicable CVX codes to Table 1: COVID-19 Vaccination Codes – Primary Series and Table 2: COVID-19 Vaccination Codes – Booster Series |
9 | 11.23.2022 | Patient-Level Detail File (PLD) | Commercial: Measure AXR:
|
9 | 11.23.2022 | Patient-Level Detail File (PLD) | Exchange: Measure BPD:
|
If there are any questions about the above edits, or if you find issues or have concerns with the 2022 Technical Specifications manual or other documents, please email nysqarr@health.ny.gov.
Sincerely,
Paloma Luisi, MPH
Director, Bureau of Quality Measurement & Evaluation
Center for Applied Research and Evaluation
Office of Quality and Patient Safety
CC: R. Josberger
M. Lurie